Blog

Peter Pisters: MD Anderson is focusing on art to support the revitalization and expansion of our clinical facilities

Peter Pisters/MD Anderson Cancer Center

Oct 29, 2024, 16:30

Peter Pisters: MD Anderson is focusing on art to support the revitalization and expansion of our clinical facilities

Peter Pisters, President at MD Anderson Cancer Center, shared a post by MD Anderson Cancer Center on LinkedIn, adding:

“As we expand our reach at MD Anderson Cancer Center, we do so with the understanding that art can have a profound impact on the healing process.

Our new spaces will foster an environment that is inspirational and conducive to many different forms of healing for our patients.”

MD Anderson Cancer Center shared:

“As part of our ongoing commitment to patient comfort and healing, MD Anderson is focusing on art to support the revitalization and expansion of our clinical facilities.

This initiative will include the creation of a multisensory healing environment in both public spaces and patient care areas.

To help cultivate and curate this environment, the institution will welcome Jennifer Finkel, Ph.D., as associate vice president for Art Experience on January 6, 2025.

In this position, Finkel will collaborate with senior leaders, patients, employees and community volunteers to curate and maintain a nationally recognized contemporary art collection and commissioned installations that foster inspiration and hope.

“Research has shown that art can improve mood, reduce stress and enhance the overall experience of a hospital visit, making it an invaluable resource for fostering healing and comfort,” says Finkel.”

Peter Pisters leads The University of Texas MD Anderson Cancer Center, driving research in cardiology, transplantation, neurosciences, oncology, surgical innovation, infectious diseases, genomic medicine, and rehabilitation medicine. He contributes to academic journals like the Journal of Clinical Oncology and Surgery, and reviews for various publications. His research, concentrated on sarcomas, GI cancers, and other malignancies.